Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease



Status:Terminated
Conditions:Peripheral Vascular Disease, Podiatry, Diabetes
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology, Orthopedics / Podiatry
Healthy:No
Age Range:18 - Any
Updated:2/21/2019
Start Date:October 23, 2014
End Date:February 28, 2018

Use our guide to learn which trials are right for you!

A Phase 2 Multicenter, Randomized, Doubleblind, Placebo-Controlled, Dose Range Finding Study to Evaluate the Efficacy and Safety of Intramuscular Injection of Human Placenta-derived Cells (Pda-002) in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

The PDA-002-DFU-002 trial is a Phase 2, multicenter, randomized, double blind, placebo
controlled, dose range finding study. The study will enroll approximately 133 subjects in
four treatment groups. The primary objective of the study is to assess the efficacy and
safety of PDA-002 administered intramuscular (IM) in subjects who have DFU with and without
PAD. The secondary objective is to explore potential clinical efficacy by assessing changes
in vascular parameters such as Ankle-Brachial Index and Toe-Brachial Index (ABI and/or TBI),
Transcutaneous oxygen measurements (TcPO2).


Inclusion Criteria:

1. Males and females, at least 18 years of age or older at the time of signing the
informed consent document.

2. Understand and voluntarily sign an informed consent document prior to any study
related assessments/procedures are conducted.

3. Able to adhere to the study visit schedule and other protocol requirements.

4. Diabetes mellitus Type 1 or Type 2.

5. Diabetic foot ulcer with severity of Grade 1 (full thickness only) or Grade 2 on the
Wagner Grading Scale (Appendix A) of greater than one month duration which has not
adequately responded to conventional ulcer therapy with a size of at least of 1cm2
except if present on the toe. The maximum lesion size range in the index ulcer is ≤
10cm2. The measurement of the index ulcer is to be evaluated and measured after
debridement (if necessary) at the Screening Visit. If located on the plantar aspect of
the foot, the index ulcer must be able to be adequately offloaded in the assessment of
the investigator.

6. No planned revascularization or amputation over the next 3 months after Screening
visit, in the opinion of the Investigator.

7. Screening should not begin until at least 14 days after a failed reperfusion
intervention and at least 30 days after a successful reperfusion intervention.

8. Subjects should be receiving appropriate medical therapy for hypertension and diabetes
any other chronic medical conditions for which they require ongoing care.

9. A female of childbearing potential must have a negative serum pregnancy test at
Screening and a negative urine pregnancy test prior to treatment with study therapy.
In addition, sexually active FCBP must agree to use 2 of the following adequate forms
of contraception methods simultaneously such as: oral, injectable, or implantable
hormonal contraception; tubal ligation; IUD; barrier contraceptive with spermicide or
vasectomized partner for the duration of the study and the Follow-up Period.

10. Males (including those who have had a vasectomy) must agree to use barrier
contraception (latex condoms) when engaging in reproductive sexual activity with FCBP
for the duration of the study and the Follow-up Period.

Exclusion Criteria:

1. Any significant medical condition, laboratory abnormality, or psychiatric illness that
would prevent the subject from participating in the study.

2. Any condition including the presence of laboratory abnormalities, which places the
subject at unacceptable risk if he or she were to participate in the study.

3. Any condition that confounds the ability to interpret data from the study.

4. Pregnant or lactating females.

5. Subjects with a body mass index > 45 kg/m2 at Screening.

6. AST (SGOT) or ALT (SGPT) > 2.5 x the upper limit of normal (ULN) at Screening.

7. Patient on renal dialysis for abnormal kidney function.

8. An ABI < 0.4 and or TBI < 0.3 in the leg with the index ulcer.

9. Bilirubin level > 2 mg/dL (unless subject has known Gilbert's disease) at Screening.

10. Untreated chronic infection or treatment of any infection with systemic antibiotics,
including the ulcer site, must be free of antibiotics within 1 week prior to dosing
with IP.

11. Active osteomyelitis, infection, or cellulites at or adjacent to the index ulcer.
Patients with a history of being treated for an osteomyelitis without a surgical
resection.

12. Index ulcer that has decreased or increased in size by ≥ 30% during the
Screening/Run-In/ Pre-Treatment Period.

13. Active Charcot Neuroarthropathy in the foot with the index ulcer

14. Pain at rest due to limb ischemia.

15. Uncontrolled hypertension (defined as diastolic blood pressure > 100 mmHg or systolic
blood pressure > 180 mmHg during Screening at 2 independent measurements taken while
subject is sitting and resting for at least 5 minutes).

16. Poorly controlled diabetes mellitus (hemoglobin A1c > 12% or a screening serum glucose
of ≥ 300mg/dl).

17. Untreated proliferative retinopathy.

18. History of malignant ventricular arrhythmia, CCS Class III-IV angina pectoris,
myocardial infarction/ percutaneous coronary intervention (PCI) / coronary artery
bypass graft (CABG) in the preceding 6 months prior to signing the informed consent
form (ICF), pending coronary revascularization in the following 3 months, transient
ischemic attack/cerebrovascular accident in the preceding 6 months, prior to signing
the ICF, and/or New York Heart Association [NYHA] Stage III or IV congestive heart
failure.

19. Abnormal ECG: new right bundle branch block (BBB) ≥ 120 msec in the preceding 3 months
prior to signing the ICF.

20. Uncontrolled hypercoagulation syndrome.

21. Life expectancy less than at 2 years at the time of signing the ICF due to concomitant
illnesses.

22. In the opinion of the Investigator, the subject is unsuitable for cellular therapy.

23. History of malignancy within 5 years prior to signing the ICF except basal cell or
squamous cell carcinoma of the skin or remote history of cancer now considered cured
or positive Pap smear with subsequent negative follow-up.

24. History of hypersensitivity to any of the components of the product formulation
(including bovine or porcine products, dextran 40, and dimethyl sulfoxide [DMSO]).

25. Subject has received an investigational agent —an agent or device not approved by the
US Food and Drug Administration (FDA) for marketed use in any indication— within 90
days (or 5 half-lives, whichever is longer) prior to treatment with study therapy or
planned participation in another therapeutic study prior to the completion of this
study.

26. Subject has received previous investigational gene or cell therapy.
We found this trial at
55
sites
2401 W Belvedere Ave
Baltimore, Maryland 21215
(410) 601-9000
Sinai Hospital of Baltimore Sinai Hospital of Baltimore provides a broad array of high-quality, cost-effective...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Miami, Florida 33124
(305) 284-2211
University of Miami A private research university with more than 15,000 students from around the...
?
mi
from
Miami, FL
Click here to add this to my saved trials
8042 Wurzbach Road
San Antonio, Texas 78229
210-949-0807
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Baltimore, Maryland 21214
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Belleville, Illinois 62226
?
mi
from
Belleville, IL
Click here to add this to my saved trials
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Birmingham, Alabama 35211
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Castro Valley, California 94546
?
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chino, California 91710
?
mi
from
Chino, CA
Click here to add this to my saved trials
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
1801 Inwood Rd
Dallas, Texas 75390
(214) 645-3300
University of Texas Southwestern Medical Center UT Southwestern is an academic medical center, world-renowned for...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Des Plaines, Illinois 60016
?
mi
from
Des Plaines, IL
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
?
mi
from
Duncansville, PA
Click here to add this to my saved trials
East Setauket, New York 11733
?
mi
from
East Setauket, NY
Click here to add this to my saved trials
350 Engle St
Englewood, New Jersey 07631
(201) 894-3000
Englewood Hospital and Medical Center Englewood Hospital was incorporated in 1888 as a non-profit, non-sectarian...
?
mi
from
Englewood, NJ
Click here to add this to my saved trials
Fort Lauderdale, Florida 33321
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Fresno, California 93721
?
mi
from
Fresno, CA
Click here to add this to my saved trials
Gainesville, Florida 32605
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Gallup, New Mexico 87301
?
mi
from
Gallup, NM
Click here to add this to my saved trials
Hialeah, Florida 33016
?
mi
from
Hialeah, FL
Click here to add this to my saved trials
Houston, Texas 77084
?
mi
from
Houston, TX
Click here to add this to my saved trials
Jacksonville, Florida 32209
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Jonesboro, Arkansas 72401
?
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Los Angeles, California 90010
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90095
(310) 825-4321
UCLA UCLA's primary purpose as a public research university is the creation, dissemination, preservation and...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
McAllen, TX
Click here to add this to my saved trials
?
mi
from
Mesa, AZ
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
Miami Lakes, Florida 33016
?
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Mobile, Alabama 36608
?
mi
from
Mobile, AL
Click here to add this to my saved trials
?
mi
from
North Chicago, IL
Click here to add this to my saved trials
North Miami Beach, Florida 33162
?
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
3801 Miranda Avenue
Palo Alto, California 94304
650-493-5000
VA Palo Alto Health Care System The VA Palo Alto Health Care System (VAPAHCS) consists...
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Philadelphia, Pennsylvania
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Randallstown, Maryland 21133
?
mi
from
Randallstown, MD
Click here to add this to my saved trials
Roanoke, Virginia
?
mi
from
Roanoke, VA
Click here to add this to my saved trials
Salt Lake City, Utah 84106
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Antonio, Texas 78229
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
327 W Calhoun Ave
Springfield, Illinois 62702
(217) 545-0223
Southern Illinois University From its humble beginnings as the state's second teachers college - founded...
?
mi
from
Springfield, IL
Click here to add this to my saved trials
Springfield, Illinois 62704
?
mi
from
Springfield, IL
Click here to add this to my saved trials
450 Serra Mall
Stanford, California 94305
(650) 723-2300
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
?
mi
from
Stanford, CA
Click here to add this to my saved trials
Sterling, Illinois 61081
?
mi
from
Sterling, IL
Click here to add this to my saved trials
Sterling Heights, Michigan 48313
?
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
?
mi
from
Suffolk, VA
Click here to add this to my saved trials
Syracuse, New York 13210
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
Tinton Falls, New Jersey 07724
?
mi
from
Tinton Falls, NJ
Click here to add this to my saved trials
Toms River, New Jersey 08753
?
mi
from
Toms River, NJ
Click here to add this to my saved trials
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Washington, District of Columbia 20057
?
mi
from
Washington,
Click here to add this to my saved trials
Wauwatosa, Wisconsin 53226
?
mi
from
Wauwatosa, WI
Click here to add this to my saved trials